Amplification and overexpression of ERBB2 encoding the human epidermal growth factor receptor 2 (HER2) distinguishes a subtype of breast cancers that accounts for approximately one-fifth of all invasive breast cancer cases (1). This evidence concerns the gene ERBB2 and breast carcinoma.